CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques (Q45420331)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Teleshova N

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kenney J

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Williams V

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Van Nest G

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Marshall J

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Lifson JD

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sivin I

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Dufour J

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Bohm R

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gettie A

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Pope M

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Journal of Leukocyte Biology

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

257-267

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Progress on new vaccine strategies for the immunotherapy and prevention of cancer

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

HIV and SIV CTL escape: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Progress toward an HIV vaccine

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

B cell antigen receptor signaling 101.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Divide and conquer: the importance of cell division in regulating B-cell responses.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

B-cell immunodeficiency in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Immunotherapeutic uses of CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Use of CpG oligodeoxynucleotides as immune adjuvants

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Toll-like receptor 9, CpG DNA and innate immunity

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Differential signaling by CpG DNA in DCs and B cells: not just TLR9

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Interferons alpha and beta as immune regulators--a new look

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Dendritic cells control B cell growth and differentiation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

The simian immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Activation of macaque T cells and B cells with agonistic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Superior activity of the type C class of ISS in vitro and in vivo across multiple species.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Modulation of dendritic cell maturation and function by B lymphocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Immunodeficiency virus exploitation of dendritic cells in the early steps of infection

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Virus infection of dendritic cells: portal for host invasion and host defense

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Interleukin 6 and its receptor: ten years later

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

In vivo expression of interleukin-8, and regulated on activation, normal, T-cell expressed, and secreted, by human germinal centre B lymphocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0205084

21 January 2018

Identifiers

10.1189/JLB.0205084

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45420331&oldid=2076901638"